Prevention of platelet-polymorphonuclear leukocyte interactions: New clues to the antithrombotic properties of parnaparin, a low molecular weight heparin

Haematologica

Volumn 90, Issue 6, 2005, Pages 833-839

  Maugeri, Norma ^a   De Gaetano, Giovanni ^a   Barbanti, Miriam ^b   Donati, Maria Benedetta ^a   Cerletti, Chiara ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Alfa Wassermann SpA   (Italy)

Author keywords

Inflammation; Low molecular weight heparin; Parnaparin; Platelet PMN interaction; Selectins

Indexed keywords

CITRIC ACID; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HEPARIN; L SELECTIN; LOW MOLECULAR WEIGHT HEPARIN; MYELOPEROXIDASE; PADGEM PROTEIN; PARNAPARIN; THROMBOPLASTIN;

ANTICOAGULATION; ARTICLE; CELL INTERACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGRANULATION; DEPOLYMERIZATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE FUNCTION; NEUTROPHIL; PROTEIN EXPRESSION; THROMBOCYTE;

ANTI-INFLAMMATORY AGENTS; BLOOD PLATELETS; CELL ADHESION; FIBRINOLYTIC AGENTS; FLOW CYTOMETRY; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; L-SELECTIN; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; P-SELECTIN; PLATELET ACTIVATION; TIME FACTORS;

EID: 21244480057     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
2. Cerletti C, Maugeri N, Evangelista V, de Gaetano G. Platelet-leukocyte interaction and atherothrombosis. In: Amout J, de Gaetano G, Hoylaerts M, Peerlinck K, Van Geet C, Verhaeghen G, editors. Thrombosis. Fundamental and clinical aspects. Leuven University Press 2003. p. 305-26
3. Mehta J, Dinerman J, Mehta P, Saldeen TGP, Lawson D, Donnelly WH, Wallin R. Neutrophil function in ischemic heart disease. Circulation 1989;79:549-56.
4. Maugeri N, Kempfer AC, Evangelista V, Cerletti C, de Gaetano G, Lazzari MA. Enhanced response to chemotactic activation of polymorphonuclear leukocyte from patients with heart valve replacement. Thromb Haemost 1997; 77:71-4.
5. Mazzone A, De Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Pasotti D, et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993;88:358-63.
6. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347:5-12.
7. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104:1533-7.
8. Mickelson JK, Lakkis NM, Villarreal-Levy G, Hughes BJ, Smith CW. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent diseased? J Am Coll Cardiol 1996;28:345-53.
9. Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998;31: 352-8.
10. Maugeri N, Santarelli MT, Lazzari MA. Circulating platelet/ polymorphonuclear leukocyte mixed-cell aggregates in patients with mechanical heart valve replacement. Am J Hematol 2000;65: 93-8.
11. Jensen MK, de Nully Brown P, Lund BV, Nielsen OJ, Hasselbalch HC. Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, glatelet activation and platelet count. Br J Haematol 2000;110:116-24.
12. Simon SI, Burns AR, Taylor AD, Gopalan PK, Lynam EB, Sklar LA, Smith CW. L-selectin (CD62L) crosslinking signals neutrophil adhesive functions via the Mac-1 (CD11b/ CD18) β 2-integrin. J Immunol 1995; 155:1502-14.
13. Rinder HM, Tracey JL, Rinder CS Leitenberg D, Smith BR. Neutrophil but not monocyte activation inhibits P-selectin-mediated platelet adhesion. Thromb Haemost 1994;71:750-6.
14. Evangelista V, Manarini S, Rotondo S, Martelli N, Polischuk R, Mc Gregor JL, et al. Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the β 2 integrin CD11b/CD18. Blood 1996;88:4183-94.
15. Evangelista V, Manarini S, Sideri R, Rotondo S, Martelli N, Piccoli A, et al. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood 1999; 93:876-85.
16. Yang J, Furie BC, Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost 1999;81:1-7.
17. Cerletti C, Evangelista V, de Gaetano G. P-Selectin-β2-integrin cross-talk: a molecular mechanism for polymorphonuclear leukocyte recruitment at the site of vascular damage. Thromb Haemost 1999;82:787-93.
18. Neumann FJ, Zohlnhofer D, Fakhoury L, Ott I, Gawaz M, Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol 1999;34: 1420-6.
19. Bertram U, Moser M, Peter K, Kuecherer HF, Bekeredjian R, Straub A, et al. Effects of different thrombolytic treatment regimen with abciximab and tirofiban on platelet aggregation and platelet-leukocyte interactions: a subgroup analysis from the GUSTO V and FASTER trials. J Thromb Thrombolysis 2002;14:197-203.
20. Nelson RM, Cecconi O, Roberts WG, Aruffo A, Linhardt RJ, Bevilacqua MP. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood 1993;82:3253-8.
21. Xie X, Rivier AS, Zakrzewicz L, Bernimoulin M, Zeng XL, Wessel HP, et al. Inhibition of Selectin-mediated cell adhesion and prevention of acute inflammation by non anticoagulant sulphated saccharides. J Biol Chem 2000; 275:34818-25.
22. Wang L, Brown JR, Varki A, Esko JD. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest 2002;110:127-36.
23. Evangelista V, Piccardoni P, Maugeri N, de Gaetano G, Cerletti C. Inhibition by heparin of platelet activation induced by neutrophil-derived cathepsin G. Eur J Pharmacol 1992;216:401-5.
24. Rajtar G, Marchi E, de Gaetano G, Cerletti C. Effects of glycosaminoglycans on platelet and leucocyte function: role of N-sulfation. Biochem Pharmacol 1993;46:958-60.
25. Leculier C, Couprie N, Adeleine P, Leitienne P, Francina A, Richard M. The effects of high molecular weight- and low molecular weight-heparins on superoxide ion production and degranulation by human polymorphonuclear leukocytes. Thromb Res 1993;69:519-31.
26. Frampton JE, Faulds D. Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders. Drugs 1994; 47:652-76.
27. Dettori AG. Parnaparin: a review of its pharmacological profile and clinical application. Drugs Today 1995;31:19-35.
28. Andriuoli G, Mastacchi R, Barbanti M, Sarret M. Comparison of the antithrombotic and haemorrhagic effects of heparin and a new low molecular weight heparin in rats. Haemostasis 1985;15:324-39.
29. Maugeri N, Evangelista V, Celardo A, Dell'Elba G, Martelli N, Piccardoni P, et al. Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane B2 and leukotriene C4 cooperative synthesis. Thromb Haemost 1994;72:450-6.
30. Brown RA, Lever R, Jones NA, Page CP. Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro. Br J Pharmacol 2003;139:845-53.
31. Walcheck B, Alexander SR, St Hill CA, Matala E. ADAM-17-independent shedding of L-selectin. J Leukoc Biol 2003;74:389-94.
32. Kishimoto TK, Jutila MA, Berg EL, Butcher EC. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 1989;245:1238-41.
33. Alexander SR, Kishimoto TK, Walcheck B. Effects of selective protein kinase C inhibitors on the proteolytic down-regulation of L-selectin from chemoattractant-activated neutrophils. J Leukoc Biol 2000;67:415-22.
34. Campanella GS, Lee EM, Sun J, Luster AD. CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10). J Biol Chem 2003;278:17066-74.
35. Murphy CT, Riley AM, Lindley CJ, Jenkins DJ, Westwick J, Potter BV. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors. Mol Pharmacol 1997;52:741-8.
36. Maes K, Missiaen L, Parys JB, De Smet P, Sienaert I, Waelkens E, et al. Mapping of the ATP-binding sites on inositol 1,4,5-trisphosphate receptor type 1 and type 3 homotetramers by controlled proteolysis and photoaffinity labeling. J Biol Chem 2001;276: 3492-7.
37. Mathias RS, Mikoshiba K, Michikawa T, Miyawaki A, Ives HE. IP3 receptor blockade fails to prevent intracellular Ca2+ release by ET-1 and α-thrombin. Am J Physiol 1998;274:C1456-65.
38. Tiozzo R, Cingi MR, Reggiani D, Andreoli T, Calandra S, Milani MR, et al. Effect of the desulfation of heparin on its anticoagulant and anti-proliferative activity. Thromb Res 1993;70:99-106.
39. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340: 115-26.
40. Molino M, Di Lallo M, Martelli N, de Gaetano G, Cerletti C. Effects of leukocyte-derived cathepsin G on platelet membrane glycoprotein Ib-IX and IIb-IIIa complexes: a comparison with thrombin. Blood 1993;82:2442-51.
41. Pintucci G, Iacoviello L, Castelli MP, Amore C, Evangelista V, Cerletti C, et al. Cathepsin G-induced release of PAI-1 in the culture medium of endothelial cells: a new thrombogenic role for polymorphonuclear leukocytes?. J Lab Clin Med 1993;122:69-79.
42. Goel MS, Diamond SL. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets. J Biol Chem 2003;278: 9458-63.
43. Maugeri N, de Gaetano G, Donati MB, Cerletti C. Polymorphonuclear leukocytes express tissue factor after activation. Haematologica 2004;89 Suppl 8: 23.
44. Maugeri N, de Gaetano G, Carbone A, Donati MB, Cerletti C. More on: tissue factor in neutrophils. J Thromb Haemost 2005;3:1114.